Veran Medical Technologies, a St. Louis, MO-based company that focuses on developing innovative care for minimally invasive delivery of interventional oncology therapies, has completed an over $15m round of financing.
Participants included existing investors and a new strategic partner.
The company intends to use the funds to commercialize clinical products built on the its IG4 platform technology, which uses proprietary 4-D registration capabilities for targeting lesions within the human body.
Veran is led by president and CEO Jerome Edwards.
FinSMEs
18/03/2011